Empresa Arrowhead Research Corp Nasdaq
Acciones
US0427972098
Biotecnología e investigación médica
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Innovative Drugs
100,0
%
| 243 | 100,0 % | 241 | 100,0 % | -1,03 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 243 | 100,0 % | 241 | 100,0 % | -1,03 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 54 | 01/12/07 | |
Director of Finance/CFO | 57 | 01/01/09 | |
Peter Carignan
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/22 |
Patrick O'brien
CMP | Compliance Officer | 60 | 01/12/14 |
Bruce Given
COO | Chief Operating Officer | 69 | 26/10/11 |
Vincent Anzalone
IRC | Investor Relations Contact | - | - |
Aaron Tan
AUD | Comptroller/Controller/Auditor | - | 01/07/21 |
Nadia Meshkova
TRE | Treasurer | - | - |
Tracie Oliver
PRN | Corporate Officer/Principal | 62 | 01/06/22 |
Matt Pulisic
PRN | Corporate Officer/Principal | - | 01/08/20 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Douglass Given
CHM | Chairman | 71 | 23/11/10 |
Michael Perry
BRD | Director/Board Member | 64 | 19/12/11 |
Adeoye Olukotun
BRD | Director/Board Member | 79 | 01/09/20 |
Hong Bo Lu
BRD | Director/Board Member | 53 | 01/04 |
Chief Executive Officer | 54 | 01/12/07 | |
William Waddill
BRD | Director/Board Member | 67 | 01/01/18 |
Mauro Ferrari
BRD | Director/Board Member | 64 | 19/08/10 |
Director/Board Member | 60 | 02/05/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 124 200 230 | 118 638 599 ( 95,52 %) | 0 | 95,52 % |
Información de la empresa
Arrowhead Pharmaceuticals, Inc.
177 East Colorado Boulevard Suite 700
91105, Pasadena
+626 304 3400
http://www.arrowheadpharma.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
+8,63 % | 114 mil M | |
+13,17 % | 107 mil M | |
-12,76 % | 22,22 mil M | |
-4,08 % | 21,28 mil M | |
-7,19 % | 17,51 mil M | |
-39,93 % | 17,17 mil M | |
+6,67 % | 14,14 mil M | |
+33,90 % | 12,2 mil M | |
-28,60 % | 7830,9 M |